Abbott Alinity m HBV Device Misquantitation of Negative Samples
Abbott Molecular recalled Alinity m HBV Application Specification Files due to potential for incorrect high quantitation results on negative samples, which could affect test accuracy for hepatitis B virus detection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device with a potential for measurement error that could affect diagnostic accuracy. No illnesses or injuries have been reported. This qualifies as a risk-of-harm product where injury has not yet been reported, meeting the High severity criteria.
Plain-English summary
Abbott Molecular, Inc. issued a recall for the Alinity m HBV Application Specification File (US and CE versions) used in hepatitis B virus testing. The issue involves a potential for misquantitation, where negative samples may be reported as having high quantitation results, potentially leading to inaccurate test outcomes.
This recall affects healthcare facilities and laboratories in the United States (Arizona, California, Illinois, Indiana, Massachusetts, Michigan, Missouri, New Hampshire, New Jersey, New York, Ohio, South Dakota, Texas, and Virginia) and internationally in Australia, Austria, Belgium, Brazil, Canada, Colombia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam.
The affected specification files are: 08N47-03A (US, Version 1.00), 08N47-01B (CE, Version 2.00), and 08N47-01C (CE, Version 3.00). The source documentation does not provide specific instructions for remediation or corrective actions.
The recalled product
- Product
- Alinity m HBV Application Specification File (US and CE)
- Manufacturer
- Abbott Molecular, Inc.
- Hazard
- quantitation-error
- false-positive
- diagnostic-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- List Numbers: 1) 08N47-03A (US)
- Version 1.00 2) 08N47-01B (CE)
- Version 2.00 3) 08N47-01C (CE)
- Version 3.00
Distribution
Distributed in 14 states:
- AZ
- CA
- IL
- IN
- MA
- MI
- MO
- NH
- NJ
- NY
- OH
- SD
- TX
- VA
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03